TechBloomberg Technology
Boehringer Signs Deal for Owkin AI, Joining Astra and Sanofi
Boehringer Ingelheim GmbH agreed to use Owkin’s artificial-intelligence model to help discover new oncology and immunology medicines.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Boehringer Ingelheim GmbH agreed to use Owkin’s artificial-intelligence model to help discover new oncology and immunology medicines.
Join the argument
House rules →Comments load as you scroll.